Endocrine consequences of opioid therapy

Psychoneuroendocrinology

Volumn 34, Issue SUPPL. 1, 2009, Pages

  Aloisi, Anna Maria ^a   Aurilio, Caterina ^b   Bachiocco, Valeria ^c   Biasi, Giovanni ^d   Fiorenzani, Paolo ^a   Pace, Maria Caterina ^b   Paci, Valentina ^f   Pari, Gilberto ^f   Passavanti, Giandomenico ^g   Ravaioli, Laura ^f   Sindaco, Gianfranco ^f   Vellucci, Renato ^e   Ceccarelli, Ilaria ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY HOSPITAL OF SIENA   (Italy)

^e CAREGGI UNIVERSITY HOSPITAL   (Italy)

^f Villa Serena Hospital   (Italy)

^g MISERICORDIA HOSPITAL   (Italy)

Author keywords

Gonadal hormones; Hypogonadism; Opioids; Pain

Indexed keywords

ANASTROZOLE; ANDROSTANOLONE; BUPRENORPHINE; ESTRADIOL; FENTANYL; FINASTERIDE; FOLLITROPIN; HYDROCORTISONE; LUTEINIZING HORMONE; MORPHINE; OPIATE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; STEROID HORMONE; TESTOSTERONE;

ANALGESIA; ANDROGEN DEFICIENCY; ARTICLE; GLIA CELL; GLIOMA CELL; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; IN VITRO STUDY; NONHUMAN; POSTOPERATIVE PAIN; PRIORITY JOURNAL; SEX DIFFERENCE;

ADMINISTRATION, CUTANEOUS; ANALGESICS, OPIOID; ANIMALS; BUPRENORPHINE; CELLS, CULTURED; ENDOCRINE SYSTEM; FEMALE; GONADAL HORMONES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INJECTIONS, SPINAL; MALE; MORPHINE; PITUITARY-ADRENAL SYSTEM; SEX CHARACTERISTICS; TESTOSTERONE;

EID: 71249159638     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2009.05.013     Document Type: Article

References (38)

1. Abs R., Verhelst J., Maeyaert J., Van Buyten J.P., Opsomer F., Adriaensen H., Verlooy J., Van Havenbergh T., Smet M., and Van Acker K. Endocrine consequences of long-term intrathecal administration of opioids. J. Clin. Endocrinol. Metab. 85 (2000) 2215-2222
2. Ahlbom E., Grandison L., Bonfoco E., Zhivotovsky B., and Ceccatelli S. Androgen treatment of neonatal rats decreases susceptibility of cerebellar granule neurons to oxidative stress in vitro. Eur. J. Neurosci. 11 (1999) 1285-1291
3. Aloisi A.M., and Bonifazi M. Sex hormones, central nervous system and pain. Horm. Behav. 50 (2006) 1-7
4. Aloisi A.M., Pari G., Ceccarelli I., Vecchi I., Ietta F., Lodi L., and Paulesu L. Gender-related effects of chronic non-malignant pain and opioid therapy on plasma levels of macrophage migration inhibitory factor (MIF). Pain 115 (2005) 142-151
5. Aloisi A.M., Ceccarelli I., Fiorenzani P., De Padova A.M., and Massafra C. Testosterone affects formalin-induced responses differently in male and female rats. Neurosci. Lett. 361 (2004) 262-264
6. Amini H., and Ahmadiani A. In vivo evidence for an increase in 5alpha-reductase activity in the rat central nervous system following morphine exposure. Int. J. Dev. Neurosci. 23 (2005) 621-626
7. Behl C., Skutella T., Lezoulac'h F., Post A., Widmann M., Newton C.J., and Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 51 (1997) 535-541
8. Ceccarelli I., De Padova A.M., Fiorenzani P., Massafra C., and Aloisi A.M. Single opioid administration modifies gonadal steroids in both the CNS and plasma of male rats. Neuroscience 140 (2006) 929-937
9. Ceccarelli I., Scaramuzzino A., Massafra C., and Aloisi A.M. The behavioral and neuronal effects induced by repetitive nociceptive stimulation are affected by gonadal hormones in male rats. Pain 104 (2003) 35-47
10. Cicero T.J., Wilcox C.E., Bell R.D., and Meyer E.R. Acute reductions in serum testosterone levels by narcotics in the male rat: stereospecificity, blockade by naloxone and tolerance. J. Pharmacol. Exp. Ther. 198 (1976) 340-346
11. Daniell H.W. Hypogonadism in men consuming sustained-action oral opioids. J. Pain 3 (2002) 377-384
12. Daniell H.W., lentz R., and Mazer N.A. Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency. J. Pain 7 (2006) 200-210
13. Daniell H.W. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain. J. Pain 9 (2008) 28-36
14. Dessein P.H., Shipton E.A., Stanwix A.E., and Joffe B.I. Neuroendocrine deficiency-mediated development and persistence of pain in fibromyalgia: a promising paradigm?. Pain 86 (2000) 213-215
15. Engeland C.G., Sabzehei B., and Marucha P.T. Sex hormones and mucosal wound healing. Brain Behav. Immun. December (2008) (epub ahead of print)
16. Engeland C.G., Bosch J.A., Cacioppo J.T., and Marucha P.T. Mucosal wound healing: the roles of age and sex. Arch. Surg. 141 (2006) 1193-1197
17. English K.M., Steeds R.P., Jones T.H., Diver M.J., and Channer K.S. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation 102 (2000) 1906-1911
18. Fabbri A., Jannini E.A., Gnessi L., Ulisse S., Moretti C., and Isidori A. Neuroendocrine control of male reproductive function. The opioid system as a model of control at multiple sites. J. Steroid Biochem. 32 (1989) 145-150
19. Fargo K.N., Galbiati M., Foecking E.M., Poletti A., and Jones K.J. Androgen regulation of axon growth and neurite extension in motoneurons. Horm. Behav. 53 (2008) 716-728
20. Fuller S.J., Tan R.S., and Martins R.N. Androgens in the etiology of Alzheimer's disease in aging men and possible therapeutic interventions. J. Alzheimer Dis. 12 (2007) 129-142
21. Gilliver S.C., and Ashcroft G.S. Sex steroids and cutaneous wound healing: the contrasting influences of estrogens and androgens. Climacteric 10 (2007) 276-288
22. Goodman Y., Bruce A.J., Cheng M., and Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J. Neurochem. 66 (1996) 1836-1844
23. Harbuz M.S., Perveen-Gill Z., Lightman S.L., and Jessop D.S. A protective role for testosterone in adjuvant-induced arthritis. Br. J. Rheumatol. 34 (1995) 1117-1122
24. Jenab S., and Morris P.L. Interleukin-6 regulation of kappa opioid receptor gene expression in primary sertoli cells. Endocrine 13 (2000) 11-15
25. Jordan D., Tafani J.A., Ries C., Zajac J.M., Simonnet G., Martin D., Kopp N., and Allard M. Evidence for multiple opioid receptors in the human posterior pituitary. J. Neuroendocrinol. 8 (1996) 883-887
26. Lee A.W., and Pfaff D.W. Hormone effects on specific and global brain functions. J. Physiol. Sci. 58 (2008) 213-220
27. Kaergaard A., Hansen A.M., Rasmussen K., and Andersen J.H. Association between plasma testosterone and work-related neck and shoulder disorders among female workers. Scand. J. Work Environ. Health 26 (2000) 292-298
28. Mitra S. Opioid-induced hyperalgesia: pathophysiology and clinical implications. J. Opioid Manag. 4 (2008) 123-130
29. Morales A.J., Nolan J.J., Nelson J.C., and Yen S.S. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab. 78 (1994) 1360-1367
30. Pimpinelli F., Parenti M., Guzzi F., Piva F., Hokfelt T., and Maggi R. Presence of delta opioid receptors on a subset of hypothalamic gonadotropin releasing hormone (GnRH) neurons. Brain Res. 1070 (2006) 15-23
31. Pirnik Z., Schwendt M., and Jezova D. Single dose of morphine influences plasma corticosterone and gene expression of main NMDA receptor subunit in the adrenal gland but not in the hyppocampus. Endocr. Regul. 35 (2001) 187-193
32. Rajagopal A., Vassilopoulou-Sellin R., Palmer J.L., Kaur G., and Bruera E. Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy. J. Pain Symptom Manag. 26 (2003) 1055-1061
33. Rasor III J., and Harris G. Opioid use for moderate to severe pain. J. Am. Osteopath. Assoc. 105 (2005) S2-S7
34. Roberts L.J., Finch P.M., Pullan P.T., Bhagat C.I., and Price L.M. Sex hormone suppression by intrathecal opioids: a prospective study. Clin. J. Pain 18 (2002) 144-148
35. Sacerdote P. Opioid-induced immunosuppression. Curr. Opin. Support Palliat. Care 2 (2008) 14-18
36. Smith Y.R., Stohler C.S., Nichols T.E., Bueller J.A., Koeppe R.A., and Zubieta J.K. pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. J. Neurosci. 26 (2006) 5777-5785
37. Tutak U., and Doleys D.M. Intrathecal infusion systems for treatment of chronic low back and leg pain of noncancer origin. South Med. J. 89 (1996) 295-300
38. Vegeto E., Benedusi V., and Maggi A. Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases. Front. Neuroendocrinol. 29 (2008) 507-519